Digital AI and the Big Data paradigm – big ambitions in novel drug d... Over the past few decades, data generation has veritably exploded.
Digital It’s time for more tech and biotech innovation in 2023 The drive to make the UK a ‘scientific powerhouse’ was central to the government’s
R&D How decentralised storage networks can change the game for t... The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about
Digital Is the proposed Data Protection and Digital Information Bill... A new Data Protection and Digital Information Bill is currently being considered by UK ministers.
Digital A few of 2022’s biggest pharma trends – the pharmaphorum pod... As we close out the year, pharmaphorum's editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of
Healthcare How medical device sales teams can embrace digital transform... Selling amid a global pandemic has changed the face of sales forever.
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
